Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis
- 1 December 2009
- journal article
- review article
- Published by Elsevier in Respiratory Medicine
- Vol. 103 (12) , 1777-1790
- https://doi.org/10.1016/j.rmed.2009.07.010
Abstract
No abstract availableKeywords
This publication has 113 references indexed in Scilit:
- Mutations at embB Codon 306 Are an Important Molecular Indicator of Ethambutol Resistance in Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2009
- Epidemiology and Treatment of Multidrug Resistant TuberculosisSeminars in Respiratory and Critical Care Medicine, 2008
- Transfer of embB Codon 306 Mutations into Clinical Mycobacterium tuberculosis Strains Alters Susceptibility to Ethambutol, Isoniazid, and RifampinAntimicrobial Agents and Chemotherapy, 2008
- In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxideJournal of Antimicrobial Chemotherapy, 2008
- Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of TuberculosisAntimicrobial Agents and Chemotherapy, 2008
- Evaluation of a semi-automated reporter phage assay for susceptibility testing of Mycobacterium tuberculosis isolates in South AfricaTuberculosis, 2008
- Drug Therapy of Experimental Tuberculosis (TB): Improved Outcome by Combining SQ109, a New Diamine Antibiotic, with Existing TB DrugsAntimicrobial Agents and Chemotherapy, 2007
- Combinations of R207910 with Drugs Used To Treat Multidrug-Resistant Tuberculosis Have the Potential To Shorten Treatment DurationAntimicrobial Agents and Chemotherapy, 2006
- Microscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TBNew England Journal of Medicine, 2006
- Population Genetics Study of Isoniazid Resistance Mutations and Evolution of Multidrug-Resistant Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2006